(VIANEWS) – Shares of Moderna (NASDAQ Composite: MRNA) dropped 5.71% to $210.17 at 03:27 EST on Friday, following the last session’s downward trend. NASDAQ Composite is rising 0.05% to $14,942.83, following the last session’s downward trend. This seems, so far, a somewhat bullish trend exchanging session today.

Moderna’s last close was $210.17, 57.75% below its 52-week high of $497.49.

Volume

Today’s last reported volume for Moderna is 7359795 which is 37.3% below its average volume of 11739074.

Moderna’s Sales

Moderna’s sales growth is 8216.6% for the current quarter and 1202.8% for the next. The company’s growth estimates for the current quarter and the next is 1694.9% and 1681.2%, respectively.

Moderna’s Revenue

Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.

Volatility

Moderna’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.47%, a negative 0.70%, and a positive 4.56%, respectively.

Moderna’s highest amplitude of average volatility was 5.17% (last week), 4.62% (last month), and 4.56% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Moderna’s stock is considered to be overbought (>=80).

Moderna’s Stock Yearly Top and Bottom Value

Moderna’s stock is valued at $210.17 at 03:27 EST, way under its 52-week high of $497.49 and way above its 52-week low of $102.66.

Moderna’s Moving Average

Moderna’s worth is way under its 50-day moving average of $298.96 and way below its 200-day moving average of $267.83.

Previous days news about Moderna (MRNA)

  • Moderna inc (mrna) stock price and forecast: Moderna works on omicron booster. According to FXStreet on Tuesday, 11 January, "However, as more and more evidence mounted that Omicron appears less severe, Moderna has resumed the downtrend with the occasional spike as witnessed yesterday."

More news about Moderna (MRNA).

LEAVE A REPLY

Please enter your comment!
Please enter your name here